How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 701–800 of 1,008
Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 37
“Pro-inflammatory (M1) or anti-inflammatory (M2) types of microglial activation have previously been discovered (Ransohoff 2016).”
BackgroundDumitrache, L. C., Shimada, M., Downing, S. M., Kwak, Y. D., Li, Y., Illuzzi, J. L., Russell, H. R., Wilson, D. M., & McKinnon, P. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809682115 · Cited by 32
Connecting the dots: Neuronal senescence, stress granules, and neurodegeneration
Ma, Y., & Farny, N. G. (2023) · Gene · doi:10.1016/j.gene.2023.147437 · Cited by 33
Neuron-immunity communication: mechanism of neuroprotective effects in EGCG
Chen, Y., Liu, Z., & Gong, Y. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2212069 · Cited by 35
“Current research suggests that the onset of neurodegenerative diseases is not only influenced by aging (Armstrong 2020), but also by inflammation, obesity, environment, and other factors (Chen, Zhang, and Huang 2016; Mazon et al. 2017; Ransohoff 2016).”
Avola, R., Furnari, A. G., Graziano, A. C. E., Russo, A., & Cardile, V. (2024) · Antioxidants · doi:10.3390/antiox13020178 · Cited by 37
“2 of Neu-roin fl ammation is a common feature of many brain diseases such as Alzheimer’s disease, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal lobar dementia (FTLD), Huntington’s disease (HD) and multiple sclerosis (MS); therefore, targeting management [2,4,5].”
BackgroundInfluentialGao, S., Shen, R., Li, J., Jiang, Y., Sun, H., Wu, X., Li, X., Miao, C., He, M., Wang, J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410564121 · Cited by 33
“Microglia, as the intrinsic immune cells of the brain, are pivotal in both the emergence and progres sion of neuroinflammation ( 34 ).”
Edwards, N. C., Lao, P. J., Alshikho, M. J., Ericsson, O. M., Rizvi, B. M., Petersen, M. E., O’Bryant, S. E., Aguilar, L. F., Simoes, S., Mapstone, M. E., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae331 · Cited by 35
Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
Zhang, Y., Chen, J., Li, Y., Jiao, B., & Luo, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102595 · Cited by 38
Influence of biological sex on neuroinflammatory dynamics in the aging brain
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1670175 · Cited by 43
“…establish a self-reinforcing inflammatory loop that compromises neural homeostasis and increases susceptibility to cognitive decline and neurodegeneration (Di Benedetto et al., 2017; DiSabato et al., 2016; Colonna and Butovsky, 2017; Ransohoff, 2016; Teleanu et al., 2022; Wendimu and Hooks, 2022).”
Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells
Galán-Ganga, M., García‐Yagüe, Á. J., & Lastres‐Becker, I. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00664-w · Cited by 31
“The ligand CX3CL1 is expressed in neurons and its receptor CX3CR1 in microglia (Ransohoff 2016; Bisht et al.”
BackgroundKelty, T. J., Schachtman, T. R., Mao, X., Grigsby, K. B., Childs, T. E., Olver, T. D., Michener, P. N., Richardson, R. A., Roberts, C. K., & Booth, F. W. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2019 · Cited by 33
Entanglement of CCR5 and Alzheimer’s Disease
Li, T., & Zhu, J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00209 · Cited by 36
“…of neuroinflammation and AD are abundant and comprehensive (for more detail, we recommend Ref; Josef Karkos, 2003; Heppner Frank et al., 2015; Ransohoff, 2016; Cuello, 2017), we will focus on the relationship between microglia and neuroinflammation because microglia harbor the majority of…”
BackgroundSpanier, J. A., Nashold, F. E., Nelson, C. D., Praska, C. E., & Hayes, C. E. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577105 · Cited by 31
Lemus‐Conejo, A., Millán-Linares, M. C., Toscano, R., Millán, F., Pedroche, J., Muriana, F. J. G., & la Paz, S. M. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1763058 · Cited by 31
“vation, the neuroinflammation turns into a driving force in the development of various neurodegenerative disorders [17,37,45].”
BackgroundCatalão, C. H. R., Santos-Júnior, N. N., da Costa, L. H. A., Souza, A. D. O., Cárnio, E. C., Sebollela, A. S., Alberici, L. C., & Rocha, M. J. A. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00222-z · Cited by 37
“Based on the cognitive impact of SAE, and the consequent risk for the development of dementias, it becomes essential to develop strategies to attenuate the neurodegenerative processes triggered by SAE (Benveniste et al. 2001; Ransohoff 2016).”
BackgroundModulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model
Mollá, B., de Heredia, M. L., & Sanz, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02285-1 · Cited by 30
Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Ghasemi, M., Keyhanian, K., & Douthwright, C. L. (2021) · Cells · doi:10.3390/cells10020249 · Cited by 36
“One of the common features of various neurodegenerative diseases including ALS is glial activation and elevated levels of inflammatory markers [133,178].”
BackgroundTondo, G., Boccalini, C., Caminiti, S. P., Presotto, L., Filippi, M., Magnani, G., Frisoni, G. B., Iannaccone, S., & Perani, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201351 · Cited by 29
Three new alkaloids from Portulaca oleracea L. and their bioactivities
Cui, X., Ying, Z., Ying, X., Jia, L., & Yang, G. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.105020 · Cited by 30
Nasir, N. N., Sekar, M., Fuloria, S., Gan, S. H., Rani, N. N. I. M., Ravi, S., Begum, M. Y., Chidambaram, K., Sathasivam, K. V., Jeyabalan, S., et al. (2022) · Molecules · doi:10.3390/molecules27030734 · Cited by 31
“The immune response of the central nervous system (CNS) (also known as “neuroinflammation”) is becoming more recognised as a key factor in the aetiology and progression of major neurodegenerative and mental illnesses [25].”
BackgroundBindu, S., Dandapat, S., Manikandan, R., Dinesh, M., Anbazhagan, S., Pashupathi, M., Dhawan, M. K., Tiwari, R., Bilal, M., Emran, T. B., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2040238 · Cited by 36
“Systemic inflammation allows the microglia to be reprogrammed, leading to potentially hyper-responsive ‘trained‘ brain immune system states.(84) Microglia has been recognized as crucial players in developing any disease conditions in the central nervous system.”
BackgroundIntracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics
Kaur, J., Singh, H., & Naqvi, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03289-9 · Cited by 33
“But when pro-inflammatory mediators are released persistently, the immune competent cells are diverted from beneficial to detrimental neurodegenerativelike situations [8, 9].”
BackgroundEmerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors
D’Alessandro, G., Limatola, C., & Catalano, M. (2018) · Current Neuropharmacology · doi:10.2174/0929867324666170713103621 · Cited by 30
“This is often referred to as M2-like phenotype, in analogy with macrophages ([73], but see also [74]).”
BackgroundPhenotypic heterogeneity of astrocytes in motor neuron disease
Trias, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 30
“term “neuroinflammation” has been used to describe the key phenomenon involving the glia-mediated pathology of these diseases.(1) Among the glial cell types, such as astrocytes,”
BackgroundDl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
Chen, Y., Wu, T., Li, H., Li, X., Li, Q., Zhu, X., Yu, M., Kuo, S., Huang, F., & Wu, Y. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00044 · Cited by 30
“In recent decades, the importance of neuroinflammation in PD progression has been realized (Ransohoff, 2016; Janda et al., 2018; Sommer et al., 2018).”
BackgroundInfluentialEmmerich, K., White, D. T., Kambhampati, S. P., Casado, G. L., Fu, T.-M., Chunawala, Z., Sahoo, A., Nimmagadda, S., Krishnan, N., Saxena, M. T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04898-9 · Cited by 29
Zhang, J., Liu, S., Wu, Y., Tang, Z., Wu, Y., Qi, Y., Dong, F., & Wang, Y. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01440-7 · Cited by 33
“However, efferent immunity is restricted by the blood–brain barrier under normal physiological conditions (Ransohoff 2016; Engelhardt et al. 2017).”
Liu, J., Liang, Y., Meng, Q., Chen, J., Ma, J., Zhu, H. Y., Cai, L., Song, N., Ding, J., Fan, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn4845 · Cited by 32
“In addition to the neuro-toxic effects, hyperreactive microglia may have protective actions on the viability and function of neurons ( 11 – 13 ).”
BackgroundIntermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential
Lv, R., Liu, B., Jiang, Z., Zhou, R., Liu, X., Lu, T., Bao, Y., Huang, C., Zou, G., Zhang, Z., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156104 · Cited by 37
Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease
Richards, R. I., Robertson, S. A., & Kastner, D. L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy139 · Cited by 29
“Such observations have contributed to the view that the neuroinflammatory response is simply a process to clear debris and recover homeostasis (55,56).”
BackgroundMonzón, M., Hernández, R. S., Garcés, M., Sarasa, R., & Badiola, J. J. (2018) · Medicine · doi:10.1097/md.0000000000010320 · Cited by 31
Extracellular vesicles can act as a potent immunomodulators of human microglial cells
Jonavičė, U., Tunaitis, V., Kriaučiūnaitė, K., Jarmalavičiūtė, A., & Pivoriūnas, A. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2810 · Cited by 29
“Microglia play a fundamental role in the initiation and support of chronic neuroinflammation accompanying many neurodegenerative diseases (Ransohoff, 2016).”
BackgroundSearching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis
Alonso, R., Pisa, D., & Carrasco, L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00171 · Cited by 30
“First, microbial infection is consistent with neuroinflammation in ALS, with a clear infiltration of T lymphocytes (Henkel et al., 2004; Hooten et al., 2015; Ransohoff, 2016).”
BackgroundKandasamy, M., Radhakrishnan, R. K., Abirami, G. P. P., Roshan, S. A., Yesudhas, A., Kadalmani, B., Prahalathan, C., Sellathamby, S., Moorthy, A., Essa, M. M., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02833-1 · Cited by 28
Potassium channels and their emerging role in parkinson's disease
Zhang, L., Zheng, Y., Xie, J., & Shi, L. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.004 · Cited by 35
Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers
Stokholm, M. G., Garrido, A., TOLOSA, E. S., Serradell, M., Iranzo, Á., Østergaard, K., Borghammer, P., Møller, A., Parbo, P., Stær, K., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09830-3 · Cited by 31
Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders
Kokkosis, A. G., & Tsirka, S. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266163 · Cited by 34
Diesel exhaust impairs TREM2 to dysregulate neuroinflammation
Greve, H. J., Mumaw, C. L., Messenger, E. J., Kodavanti, P. R. S., Royland, J. L., Kodavanti, U. P., & Block, M. L. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02017-7 · Cited by 30
“Microglia, the myeloid cell of the brain parenchyma, function as immune sentinels and are a prominent source of neuroinflammation in the CNS during disease [13, 14], which is implicated as a central mechanism of many neurodegenerative diseases, including AD [15].”
BackgroundNeurovascular inflammation in the pathogenesis of brain arteriovenous malformations
Krithika, S., & Surendran, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30226 · Cited by 32
“contribute to the neuroinflammatory process together with microglia (Ransohoff, 2016).”
BackgroundJF1/B6F1 Ngly1−/− mouse as an isogenic animal model of NGLY1 deficiency
Asahina, M., Fujinawa, R., Fujihira, H., Masahara-Negishi, Y., Andou, T., Tozawa, R., & Suzuki, T. (2021) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.97.005 · Cited by 30
Feng, X., Hu, H.-D., Chen, J., Long, C., Yang, L., & Wang, L. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.216 · Cited by 30
Theoharides, T. C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090860 · Cited by 31
Park, J., Leem, Y., Park, J., Kim, D., Kang, J. L., & Kim, H.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084420 · Cited by 36
“Neuroinflammation is a key factor in the onset and progression of neurodegenerative disorders such as Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis [1,2].”
BackgroundTakata, K., Kimura, H., Yanagisawa, D., Harada, K., Nishimura, K., Kitamura, Y., Shimohama, S., & Tooyama, I. (2022) · Molecules · doi:10.3390/molecules27092780 · Cited by 31
“Neuroinflammation is a central pathogenic process in a variety of neurodegenerative diseases [72] and is one of the most important factors in the etiology of AD [73].”
BackgroundGalectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
Mijailović, N. R., Vesić, K., Arsenijević, D., Milojević‐Rakić, M., & Borovčanin, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.923811 · Cited by 33
“Neuroinflammation is considered the most important mechanism in neurological dysfunctions (Boitard et al., 2014) and consequently leads to neurodegeneration (Ransohoff, 2016).”
BackgroundWątroba, M., & Szukiewicz, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.962769 · Cited by 33
“However, in the further part of this work, we focus mainly on microglial cells and astrocytes (Colombo and Farina, 2016; Ransohoff, 2016).”
BackgroundGuan, T., Xiao, Y., Xie, X., Meng, N., Qi, Q., Xu, J., Jiang, X., Zhang, Z., Teng, Z., & Lv, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03853-0 · Cited by 33
Magnesium oxide use and reduced risk of dementia: a retrospective, nationwide cohort study in Taiwan
Tzeng, N., Chung, C., Lin, F., Huang, C.-F., Yeh, C., Huang, S., Lu, R., Chang, H., Kao, Y., Yeh, H., et al. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1385449 · Cited by 29
Xu, M., Ouyang, Q., Gong, J., Pescosolido, M. F., Pruett, B. S., Mishra, S., Schmidt, M., Jones, R. N., Uzun, E. D. G., Lizarraga, S. B., et al. (2017) · eNeuro · doi:10.1523/eneuro.0388-17.2017 · Cited by 33
“A microglial response can serve as a marker for neurodegeneration and may also be a target for therapeutic intervention (Ransohoff, 2016).”
BackgroundBioactive α-Pyrone Derivatives from the Endolichenic Fungus Dothideomycetes sp. EL003334
Kim, G. S., Ko, W., Kim, J. W., Jeong, M., Ko, S., Hur, J., Oh, H., Jang, J., & Ahn, J. S. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b01022 · Cited by 29
Zukotynski, K., Kuo, P. H., Mikulis, D. J., Rosa‐Neto, P., Strafella, A. P., Subramaniam, R. M., & Black, S. E. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19822 · Cited by 34
Li, X., Deng, R., Li, J., Li, H., Xu, Z., Zhang, L., Feng, L., Shu, C., Zhen, M., & Wang, C. (2023) · Theranostics · doi:10.7150/thno.85711 · Cited by 28
“leading to neuronal degeneration, including microglial cells activation, proinflammatory cytokines increase and neuronal apoptosis [5-7].”
BackgroundZhang‐James, Y., Clay, J. W. S., Aber, R. B., Gamble, H. M., & Faraone, S. V. (2024) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2024.03.023 · Cited by 36
Villadiego, J., Labrador‐Garrido, A., Franco, J. M., Leal‐Lasarte, M., Genst, E. D., Dobson, C. M., Pozo, D., Toledo‐Aral, J. J., & Roodveldt, C. (2017) · Glia · doi:10.1002/glia.23237 · Cited by 29
“Based on accumulating evidence, it is currently thought that this neuroinflammatory process directly contributes to neurodegeneration and neuronal death (Fakhoury, 2016; Glass et al., 2010; Ransohoff, 2016; Virgone-Carlotta et al., 2013), supporting the notion of non cell-autonomous processes affecting neurodegenerati…”
BackgroundCarvalho, T. G., Alves‐Silva, J., de Souza, J. M., Real, A. L. C. V., Doria, J. G., Vieira, É. L. M., Gomes, G. F., de Oliveira, A. C., de Miranda, A. S., & Ribeiro, F. M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.020 · Cited by 28
“It is well known that neurodegeneration can trigger neuroinflammation (Ransohoff, 2016).”
Hollinger, K. R., Zhu, X., Khoury, E. S., Thomas, A. G., Liaw, K., Tallon, C., Wu, Y., Prchalová, E., Kamiya, A., Rojas, C. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190588 · Cited by 30
Lim, J. S., Oh, J., Yun, H. S., Lee, J. S., Hahn, D., & Kim, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114633 · Cited by 28
Tang, H., & Harte, M. (2021) · Genes · doi:10.3390/genes12111753 · Cited by 28
“The gene expression profile of microglial activation in AD patients was distinct from existing mouse models [40], while glia can adopt a reactive nonphysiological phenotype in vitro, changing their gene expression features [41,42].”
BackgroundResearch Progress in Pharmacological Activities and Applications of Cardiotonic Steroids
Ren, J., Gao, X., Guo, X., Wang, N., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902459 · Cited by 31
“…of neurological diseases also have immuneinflammatory pathophysiological features, such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis and multiple sclerosis, which promote disease occurrence through neuron injury and blood-brain barrier dysfunction (Ransohoff, 2016).”
BackgroundWang, J., Liu, B., Sun, F., Xu, Y. X., Luan, H., Yang, M., Wang, C., Zhang, T., Zhou, Z., & Yan, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109045 · Cited by 31
Jin, Y., Wu, R., Li, L., Shen, L., Gu, Y., & Sun, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03179-6 · Cited by 30
Zhu, X., Huang, S., Kang, W., Chen, P., & Liu, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1123239 · Cited by 37
“AA is an important precursor of multiple pro-inflammatory factors (prostaglandins-2, thromboxanes-2, and leukotrienes-3) and it is involved in the main inflammatory metabolic pathways, which could trigger oxidative response and furthermore damage the vulnerable substantia nigra cells (Bazinet and Layé, 2014; Janssen a…”
BackgroundImpact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
Nair, A. K., Hulle, C. A. V., Bendlin, B. B., Zetterberg, H., Blennow, K., Wild, N., Kollmorgen, G., Suridjan, I., Busse, W. W., Dean, D., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad180 · Cited by 29
“Airway inflammation is known to provoke neuroinflammation in animal models of asthma,(9) potentially via circumventricular organs,(17,106) and there is increasing evidence suggesting that neuroinflammation contributes to neurodegeneration and Alzheimer’s disease pathophysiology.(101,103,107) In addition to direct effe…”
Tsilioni, I., & Theoharides, T. C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03493-7 · Cited by 29
“Microglia have also been implicated in neuroinflammatory [78, 81, 82] and neurodegenerative [74, 83, 84] diseases.”
BackgroundShin, J.-W., Kweon, K.-J., Kim, D., Kim, P., Jeon, T.-D., Maeng, S., & Sohn, N. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500635 · Cited by 30
Yang, Q., Chen, Q., Zhang, K.-B., Liu, Y., Zheng, J.-C., Hu, D.-X., & Luo, J. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01950-z · Cited by 33
“…plays a crucial role in the development of CCH, as pathological changes in the extracellular microenvironment release damage-associated molecular patterns (DAMPs), triggering local and systemic inflammatory reactions that result in stress and damage to neurons and glial cells [30, 35].”
Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods
Chen, H., Li, N., Cai, Y., Ma, C., Ye, Y., Shi, X., Guo, J., Han, Z., Liu, Y., & Wei, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00720 · Cited by 33
“Microglia and astrocytes are the primary mediators of neuroinflammation in the brain, and their chronic activation can disrupt tissue homeostasis, resulting in neurotoxic effects (Ransohoff, 2016).”
Traumatic Brain Injury: At the Crossroads of Neuropathology and Common Metabolic Endocrinopathies
Li, M., & Sirko, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030059 · Cited by 31
“On the other hand, such extent of neurodegeneration in diabetic mice could also be the consequence of imbalanced glial activation throughout different brain regions, creating massive neuroinflammation and, in the worst cases, a neuron-threatening environment [101,102].”
BackgroundDefective vascular signaling & prospective therapeutic targets in brain arteriovenous malformations
Winkler, E. A., Lu, A. Y., Raygor, K. P., Linzey, J. R., Jonzzon, S., Lien, B. V., Rutledge, C., & Abla, A. A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.002 · Cited by 28
Catorce, M. N., & Gevorkian, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200114125628 · Cited by 28
Ma, J., Wang, Z., Chen, S., Sun, W., Gu, Q., Li, D., Zheng, J., Yang, H., & Li, X. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02122-x · Cited by 29
George, S., Tyson, T., Rey, N. L., Sheridan, R. T. C., Peelaerts, W., Becker, K., Schulz, E., Meyerdirk, L. K., Burmeister, A. R., von Linstow, C. U., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202351 · Cited by 30
A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer’s Disease
Somaa, F. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210157 · Cited by 28
Sulforaphane enhances long-term potentiation and ameliorate scopolamine-induced memory impairment
Park, H.-S., Hwang, E., Choi, G.-Y., Kim, H., Park, K.-S., Sul, J., Hwang, Y., Choi, G. W., Kim, B. I., Park, H.-W., et al. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113467 · Cited by 27
Wang, Y., Ge, X., Yu, S. Y., & Cheng, Q. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4027 · Cited by 29
“However, continuously over-activated microglia release large amounts of superoxide, derivative oxidants, NO, TNF-α, and glutamate to damage neurons (40,41).”
Landscape of immune infiltration in entorhinal cortex of patients with Alzheimerʼs disease
Zhang, H., Cao, S., Xu, Y., Sun, X., Fei, M., Jing, Q., Xu, X., Tang, J., Niu, B., & Li, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.941656 · Cited by 30
“In recent years, increasing research evidence has revealed that neuroinflammation plays a crucial role in AD (Heneka et al., 2015; Ransohoff, 2016; Lindestam Arlehamn et al., 2019).”
BackgroundMahaman, Y. A. R., Feng, J., Huang, F., Salissou, M. T. M., Wang, J., Liu, R., Zhang, B., Li, H., Zhu, F., & Wang, X. (2022) · Nutrients · doi:10.3390/nu14204284 · Cited by 35
Lopičić, S., Svirčev, Z. B., Malešević, T. P., Kopitović, A., Ivanovska, A., & Meriluoto, J. A. O. (2022) · Microorganisms · doi:10.3390/microorganisms10122418 · Cited by 33
“As a consequence of chronic inflammation, there is dysfunction in detecting or responding to the accumulation of protein aggregates, morphological and functional disturbances of the mitochondria, dysregulation of adult neurogenesis, loss of synapses and altered synaptic plasticity [88].”
Cheng, M., Ye, C., Tian, C., Zhao, D., Li, H., Sun, Z., Miao, Y., Zhang, Q., Wang, J., & Dou, Y. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.03.004 · Cited by 42
“Microglia-mediated neuroinflammation is considered a key inducer of progressive neurodegeneration in Alzheimer’s disease (AD) [1,2].”
BackgroundYue, W., Deng, X., Wang, Z., Jiang, M., Hu, R., Duan, Y., Wang, Q., Cui, J., & Fang, Y. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00354-8 · Cited by 27
“To examine whether inhibition of the MEK/ERK pathway could manifest a general beneficial effect in other disease models, we test the effect of trametinib in an AD model expressing Aβarc [28, 29] and a polyglutamine (polyQ)-mediated SCA3 model expressing SCA3-Q84 in fly neurons [58].”
BackgroundTargets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
Chelpin, M. V. E., & Vorup‐Jensen, T. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12542 · Cited by 30
Lacher, S. E., Alazizi, A., Wang, X., Bell, D. A., Piqué-Regi, R., Luca, F., & Slattery, M. G. (2017) · Redox Biology · doi:10.1016/j.redox.2017.10.018 · Cited by 27
“AP-1 activity has never been linked directly to AD, but neuroinflammation is an important contributor to AD pathology [2,58,59].”
BackgroundTherapeutic effect of Rho kinase inhibitor FSD‑C10 in a mouse model of Alzheimer's disease
Gu, Q., Yu, J., Wu, H., Li, Y., Liu, C.-Y., Feng, L., Zhang, G., Xiao, B., & Ma, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6701 · Cited by 27
“Inflammation, mitochondrial dysfunction, and oxidative stress are considered the most prominent concomitant pathological events (5-7), being potential targets of therapeutic intervention.”
Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
Romero-Molina, C., Navarro, V., Sanchez-Varo, R., Jimenez, S., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Muñoz-Castro, C., Gutierrez, A., Vitorica, J., & Vizuete, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00421 · Cited by 27
“…two types of protein lesions, AD pathology includes loss of synapses and selective neuronal cell death, along with a chronic inflammatory response manifested by activated microglia and astrocytes (for recent review Heppner et al., 2015; Calsolaro and Edison, 2016; Ransohoff, 2016; Cuello, 2017).”
BackgroundMethyl-CpG Binding Protein 2 in Alzheimer Dementia
Kim, B., Choi, Y., Kim, H.-S., & Im, H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938196.098 · Cited by 35
“Neuroinflammation is therefore thought to be a central factor underlying the process of neurodegeneration in Alzheimer disease [12].”
BackgroundQuan, W., Xu, C., Li, X., Yang, C., Lan, T., Wang, M.-Y., Yu, D., Tang, F. R., Wang, X., & Li, Z. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110761 · Cited by 32
Song, H., Cui, J., Mossine, V. V., Greenlief, C. M., Fritsche, K. L., Sun, G. Y., & Gu, Z. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8389 · Cited by 34
“Neuroinflammation plays an important role in the pathogenesis of a number of neurodegenerative disorders (32,33).”
BackgroundLi, G., Liu, S., Wang, H., Pan, R., Tang, H., Yan, X., Wang, Y., Fu, Y., Jing, F., & Dong, J. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4548 · Cited by 26
“Studies have found a strong link between inflammatory responses in certain regions of the central nervous system, a process termed ‘neuroinflammation’ and neurodegenerative diseases (2,3).”
BackgroundFuior, E. V., Mocanu, C. A., Deleanu, M., Voicu, G., Anghelache, M., Rebleanu, D., Simionescu, M., & Călin, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111066 · Cited by 25
“Numerous major current pathologies, including cardiovascular disease [31], cancer [32], diabetes [33], and neurodegeneration [34] are associated with a chronic inflammatory process.”
BackgroundLiao, H., Winkler, J., Wißfeld, J., Shahraz, A., Klaus, C., & Neumann, H. (2021) · Glia · doi:10.1002/glia.24073 · Cited by 31
“Accumulating evidence from Parkinson's disease patients and animal experimental models also indicated that neuroinflammation involving a microglial oxidative burst contributes to disease progression (Hirsch & Hunot, 2009; Ransohoff, 2016; Tan et al., 2020).”
BackgroundSharma, A., Feng, L., Muresanu, D. F., Sahib, S., Tian, Z. R., Lafuente, J. V., Buzoianu, A. D., Nozari, A., Wiklund, L., & Sharma, H. S. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.015 · Cited by 32
Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases
Ji, W., Li, Y., Peng, H., Zhao, R., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114029 · Cited by 27
Iwasa, K., Yamamoto, S., Yamashina, K., Sakemoto, C., Yagishita-Kyo, N., Maruyama, K., Awaji, T., Takei, Y., Hirasawa, A., & Yoshikawa, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02361-2 · Cited by 27
Zhang, J., Wang, M., Zhao, Y., Zhang, Y., Gao, Y., Zhang, X., & Yang, G. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136669 · Cited by 27
Calmodulin Binding Domains in Critical Risk Proteins Involved in Neurodegeneration
O’Day, D. H. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110394 · Cited by 25
“Protein aggregation is a key pathogenic attribute of these diseases [4,5].”
BackgroundExtracellular Vesicle-Based Therapeutics in Neurological Disorders
Yuan, Y., Sun, J., You, T., Shen, W., Xu, W., Dong, Q., & Cui, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122652 · Cited by 29
“coordination, memory, and learning [75].”
Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease
Zhang, Z., Xie, X., Cai, Y., Liu, P., Liu, S., Chen, R., Wang, J., Wang, Y., Zhao, Y., Zhu, Z., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105890 · Cited by 26
Astrocytes and microglia in the coordination of CNS development and homeostasis
Lopez‐Ortiz, A. O., & Eyo, U. B. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16006 · Cited by 50
Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
Raikwar, S. P., Thangavel, R., Dubova, I., Ahmed, M. E., Selvakumar, G. P., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180422 · Cited by 31
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.